His Gene Therapy Near Approval, Spark CEO Wonders: What Price Vision? – Xconomy
Xconomy |
His Gene Therapy Near Approval, Spark CEO Wonders: What Price Vision?
Xconomy Perhaps this year, Spark Therapeutics could be the first ever in the U.S. to win approval of a gene therapy with its one-time treatment for an inherited form of blindness. But an approval could also throw Spark into the line of fire in the U.S. fight … |
